ArticleJournal of medicinal chemistry2022

Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.

Kevin B Teuscher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.